ArticleTrials2022

Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.

Maria Boesing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.